Please use symbol entry at top right of page to search

Home Infusion Therapy Market Size Worth $61.7 Billion by 2030: Grand View Research, Inc.

SAN FRANCISCO, Aug. 10, 2022 /PRNewswire/ -- The global home infusion therapy market size is expected to reach USD 61.7 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.9% from 2022 to 2030. Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.

Grand View Research Logo

Key Industry Insights & Findings from the report:

  • By product, infusion pump emerged as the largest segment in 2021 owing to the increasing use of delivery fluids such as nutrients and medications.
  • The anti-infective application segment dominated the market in 2021 as a large number of procedures are performed during the administration of medications, such as antibiotics and antifungals.
  • North America dominated the global market in 2021 owing to the increasing demand for new technologies, along with advanced healthcare infrastructure.
  • The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of diabetic patients in the region.

Read 100-page full market research report for more insights, "Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy), By Region, And Segment Forecasts, 2022 - 2030", published by Grand View Research.

Home Infusion Therapy Market Growth & Trends

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on the market growth. According to a WHO report, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth in this region.

The ongoing COVID-19 pandemic is expected to create lucrative opportunities for the market. Due to the restrictions caused by COVID-19, patients are waiting to seek treatment until they feel safe. Moreover, patients who seek infusion therapy already have diseases, which eventually weaken their immune systems. In such cases, going outside even to receive treatment becomes a potential threat. Reduced operating hours have led to difficulty in scheduling appointments as well, even if patients choose to continue treatment. Hence, home infusion therapy is expected to play a key role in supporting patients.

Home Infusion Therapy Market Segmentation

Grand View Research has segmented the global home infusion therapy market on the basis of product, application, and region:

Home Infusion Therapy Market - Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Infusion Pumps
    • Elastomeric Pumps
    • Electromechanical
    • Gravity
    • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

Home Infusion Therapy Market - Application Outlook (Revenue, USD Million, 2017 - 2030)

  • Anti-infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

Home Infusion Therapy Market - Route of Administration Outlook (Revenue, USD Million, 2017 - 2030)

  • Intramuscular
  • Subcutaneously
  • Epidural

Home Infusion Therapy Market - Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Netherlands
    • Belgium
    • Switzerland
    • Russia
    • Sweden
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia
    • South Korea
    • Malaysia
    • Indonesia
    • Singapore
    • Philippines
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Egypt

List of Key Players of Home Infusion Therapy Market

  • CVS/Coram
  • Option Care Health
  • CareFusion Corporation
  • BriovaRx/Diplomat (UnitedHealth Optum)
  • PharMerica
  • Fresenius Kabi
  • ICU Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter
  • BD
  • Caesarea Medical Electronics
  • Smiths Medical
  • Terumo Corporation
  • JMS Co. Ltd.

Check out more related studies published by Grand View Research:

  • Intravenous Infusion Pumps Market - The global intravenous infusion pumps market size is expected to reach USD 9.9 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 8.2% during the forecast period. The introduction and development of Specialty and Smart pumps are imparting crucial growth to the overall infusion pump market. Smart infusion pumps are considered an advancement that will give a boost to the market as it constitutes Error Reduction Software and Customized Drug Libraries.
  • U.S. Home Infusion Therapy Market - The U.S. home infusion therapy market size is expected to reach USD 31.7 billion by 2030, registering a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The growing geriatric population and increasing prevalence of cancer, Crohn's disease, multiple sclerosis, nutritional and immune deficiencies, infections, dehydration, and nausea & vomiting are majorly driving the growth of the market. Factors such as the increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.
  • Continuous Subcutaneous Insulin Infusion Market - The global continuous subcutaneous insulin infusion market size is expected to reach USD 7.3 billion by 2027, registering a CAGR of 10.3% over the forecast period, according to a new report by Grand View Research, Inc. The key drivers of the market include increasing number of diabetes population coupled with technological advancement in the field of diabetes care.

Browse through Grand View Research's Medical Devices Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Grand View Compass | Astra ESG Solutions 
Follow Us: LinkedIn | Twitter


Cision View original content:

SOURCE Grand View Research, Inc.

Search News

Filter Results

Publication Date
  • All

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.